Novartis to buy Anthos Therapeutics for up to $3.1B
Swiss pharmaceutical corporation Novartis AG agreed to acquire Anthos Therapeutics, Inc. for up to $3.1 billion, Blackstone Life Sciences and Anthos Therapeutics revealed in a press release on Tuesday…
